USPTO serial 78195326
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEVEN H. HARTMAN
MAURY M TEPPER III WOMBLE CARLYLE SANDRIDGE & RICE PLLCPO BOX 831RALEIGH, NC 27602UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of disorders of the Central nervous system, the immune system, the cardio-vascular system, the respiratory system, the muscular-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in ophthalmology. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 19, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 6, 2004 | PAPER RECEIVED | — | |
| Jul 22, 2004 | PETD | PETITION TO REVIVE-DENIED | — |
| May 11, 2004 | PAPER RECEIVED | — | |
| Mar 31, 2004 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Mar 31, 2004 | PAPER RECEIVED | — | |
| Jan 26, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 28, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2003 | DOCK | ASSIGNED TO EXAMINER | — |